Prepared by Dr. Priya Sharma, CFA, Director of US Markets | Reviewed by Michael Brown, Lead Editor | Report ID: IGEMINI-E444F588-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns mariott stock a Cautiously Constructive outlook for the next quarter. Key drivers include a P/E of 75.46x, 30.3% revenue expansion, and an RSI of 60 suggesting a neutral-bullish phase. We define critical support at $21681 and resistance at $26499.
Rating: Overweight | Target Price: $27462.6 | Next Earnings: Jun 16
Download Full PDF Report
Price action carved a Cup and Handle, confirmed by a 0.88x volume spike on May 08, 2026. The support at $21681 was tested.
RSI at 60 indicates a oversold state. Historical backtests suggest a +9.1% move within 10 sessions.
Free cash flow conversion remains robust at 69%, supporting the 1.44% dividend and buybacks.
EPS of $319.24 reveals high earnings quality. DuPont analysis highlights asset turnover as the key ROE driver.
Relative to Finance peers, mariott stock sits at the 75th percentile in valuation, offering a potential value opportunity.
Dark pool prints show a 32%% surge in block trades, indicating institutional accumulation before Jun 16 earnings.
Beta of 1.54 suggests mariott stock is {beta_desc} volatile than the market, influencing hedging strategies.
Options skew is toward call at the 21921.9 strike, positioning for a directional move.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $24090 | $22885.5 |
| Market Cap | $23.05B | $23.05B |
| P/E Ratio | 75.46x | 64.1x |
| EPS (TTM) | $319.24 | $287.32 |
| Dividend Yield | 1.44% | 1% |
| Revenue Growth | 30.3% | 18.2% |
| Target Price | $27462.6 | - |
| Beta | 1.54 | 1.00 |